These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34939244)

  • 1. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
    Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
    FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
    Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
    Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
    Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
    J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile.
    Murakami M; Iwamoto J; Honda A; Tsuji T; Tamamushi M; Ueda H; Monma T; Konishi N; Yara S; Hirayama T; Miyazaki T; Saito Y; Ikegami T; Matsuzaki Y
    Inflamm Bowel Dis; 2018 Apr; 24(5):1035-1044. PubMed ID: 29688473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.
    Wang S; Martins R; Sullivan MC; Friedman ES; Misic AM; El-Fahmawi A; De Martinis ECP; O'Brien K; Chen Y; Bradley C; Zhang G; Berry ASF; Hunter CA; Baldassano RN; Rondeau MP; Beiting DP
    Microbiome; 2019 Aug; 7(1):126. PubMed ID: 31472697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
    Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts.
    Lewis JD; Daniel SG; Li H; Hao F; Patterson AD; Hecht AL; Brensinger CM; Wu GD; Bittinger K; ;
    Cell Mol Gastroenterol Hepatol; 2024; 18(3):101357. PubMed ID: 38750900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.
    Wang Y; Gao X; Zhang X; Xiao Y; Huang J; Yu D; Li X; Hu H; Ge T; Li D; Zhang T
    mSystems; 2019 Dec; 4(6):. PubMed ID: 31848302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperbaric oxygen therapy ameliorates intestinal and systematic inflammation by modulating dysbiosis of the gut microbiota in Crohn's disease.
    Li Y; Sun R; Lai C; Liu K; Yang H; Peng Z; Xu D; Huang F; Tang K; Peng Y; Liu X
    J Transl Med; 2024 May; 22(1):518. PubMed ID: 38816750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma bile acids in association with Crohn's disease.
    Kiasat A; Prast-Nielsen S; Rautiainen S; Engstrand L; Andersson F; Lindberg J; Schuppe-Koistinen I; Löf Granström A; Gustafsson UO
    Scand J Gastroenterol; 2024 Jun; 59(6):674-682. PubMed ID: 38505982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
    Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
    Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between gut microbiota development and maturation of intestinal bile acid metabolism in the first 3 y of healthy Japanese infants.
    Tanaka M; Sanefuji M; Morokuma S; Yoden M; Momoda R; Sonomoto K; Ogawa M; Kato K; Nakayama J
    Gut Microbes; 2020; 11(2):205-216. PubMed ID: 31550982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease.
    Zhuang X; Tian Z; Feng R; Li M; Li T; Zhou G; Qiu Y; Chen B; He Y; Chen M; Zeng Z; Zhang S
    Inflamm Bowel Dis; 2020 Oct; 26(11):1636-1647. PubMed ID: 33026078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.
    Qu W; Liu S; Zhang W; Zhu H; Tao Q; Wang H; Yan H
    Food Funct; 2019 Sep; 10(9):5886-5897. PubMed ID: 31464319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traumatic Brain Injury Induces Gastrointestinal Dysfunction and Dysbiosis of Gut Microbiota Accompanied by Alterations of Bile Acid Profile.
    You W; Zhu Y; Wei A; Du J; Wang Y; Zheng P; Tu M; Wang H; Wen L; Yang X
    J Neurotrauma; 2022 Jan; 39(1-2):227-237. PubMed ID: 33677989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
    Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
    Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
    Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn's disease.
    Bamba S; Inatomi O; Nishida A; Ohno M; Imai T; Takahashi K; Naito Y; Iwamoto J; Honda A; Inohara N; Andoh A
    Intest Res; 2022 Jul; 20(3):370-380. PubMed ID: 33975420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.